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ABSTRACT Production of nitric oxide by macrophages is
believed to be an important microbicidal mechanism for a
variety of intracellular pathogens, including Toxoplasma gon-
dii. Mice with a targeted disruption of the inducible nitric
oxide synthase gene (iNOS) were infected orally with T. gondii
tissue cysts. Time to death was prolonged compared with
parental controls. Histologic analysis of tissue from infected
mice showed scattered small foci of inf lammation with par-
asites in various tissues of iNOS2y2 mice, whereas tissue
from the parental C57BLy6 mice had more extensive tissue
inf lammation with few visible parasites. In particular, exten-
sive ulceration and necrosis of distal small intestine and fatty
degeneration of the liver was seen in the parental mice at day
7 postinfection, as compared with the iNOS2y2 mice where
these tissues appeared normal. Serum interferon g and tumor
necrosis factor a levels postinfection were equally elevated in
both mouse strains. Treatment of the parental mice with a NO
synthase inhibitor, aminoguanidine, prevented early death in
these mice as well as the hepatic degeneration and small bowel
necrosis seen in acutely infected control parentals. These
findings indicate that NO production during acute infection
with T. gondii can kill intracellular parasites but can be
detrimental, even lethal, to the host.
The importance of cytokines in host resistance against infec-
tion with Toxoplasma gondii is well recognized (1, 2). A
number of cytokines, including interleukin (IL)-7 (2), IL-12
(3), IL-15 (4), and interferon (IFN)g (5) appear to be involved
in modulating host resistance against acute parasite infection.
The common pathway by which these cytokines increase
survival involves the induction of IFNg. This cytokine plays a
pivotal role in both acute and recrudescent chronic infection
in mice. Mice treated with an antibody that blocks the activity
of IFNg are unable to survive infection with an Toxoplasma
strain of low virulence (5). During chronic infection, admin-
istration of antibody to IFNg results in the development of
toxoplasmic encephalitis (6).
The mechanism by which IFNg protects is not completely
understood. However, at least two possible mechanisms have
been reported. First, IFNg activates oxidative killing of the
parasite by macrophages through increased production of
reactive oxygen metabolites (OH) (7–9). The synergistic action
of IFNg together with a second effector [e.g., tumor necrosis
factor (TNF) a] stimulates the production of nitric oxide
(10–12). The tumoricidial and microbicidal activity of NO
against a number of pathogens, including T. gondii, has been
reported (10, 13, 14). We recently have observed the role of
NO during acute T. gondii infection in mice with a targeted
disruption in the gene expressing interferon-regulating factor
(IRF-1) (15). This gene is up-regulated when macrophages are
stimulated with IFNg. The product of IRF-1 binds to the
promotor of the inducible nitric oxide synthase (iNOS) gene,
which culminates in the production of NO. IRF-12y2 mice
are unable to produce detectable levels of NO when infected
with T. gondii (15). These mice are more susceptible to acute
T. gondii infection when compared with their genetically
matched parental control. However, in addition to an alter-
ation in NO production, it has been reported that IRF-12y2
mice have fewer CD81 T cells (16). Because CD81 T cells are
essential for host protection against T. gondii, the contribution
of this immunologic deletion to increased susceptibility of
IRF-12y2 mice could not be separated from the effects of
NO. To clarify the importance of NO in host resistance to T.
gondii, mice with a specific deletion in the synthesis pathway of
NO were used. Mice with a targeted disruption of the iNOS
gene (17) were orally infected with T. gondii. In spite of
uncontrolled hematogenous dissemination of the parasite in
the iNOS2y2 mice, these mice survived significantly longer
with less evidence of pathologic changes to their liver and gut
than the parental controls.
MATERIALS AND METHODS
Parasites and Mice. The 76K strain of T. gondii in this study
was provided by Daniel Bout, Tours, France. This strain is
maintained by continuous oral passage of cysts as previously
described (18, 19). Cysts were isolated from infected tissue,
enumerated, and used to orally infect mice. Control and test
mice were challenged with 50 cysts, except as otherwise noted.
Control mice were challenged via oral administration with an
equal quantity of uninfected mouse brain tissue. For quanti-
tation of parasite burden we used RH strain tachyzoites that
are regularly maintained in our laboratory by serial passage in
human fibroblast cells.
Breeding pairs of mice (C57BLy6X129) were kindly pro-
vided by John MacMicking (Cornell University Medical Col-
lege, NY), John Mudgett (Merck Research Laboratories,
Rahway, NJ), and Carl Nathan (Cornell University Medical
College, NY). These mice have a targeted deletion of the iNOS
gene as previously described (17). The mice were backcrossed
for five generations to wild-type C57BLy6. The absence of
iNOS gene was confirmed by PCR.
In preliminary experiments C57BLy6X129 were used as the
control. We observed histological changes in both the liver and
intestine at the microscopic and gross level. An identical
observation in the histology of the liver and intestine was
confirmed in uncrossed C57BLy6 mice. Based on these ob-
servations, C57BLy6 mice were used as the control in these
studies because of their greater availability. These mice were
bred under approved conditions in the Animal Research
Facility at Dartmouth Medical School. Before the study,
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offspring were analyzed for expression of iNOS (20). Five- to
six-week-old female mice were used in these studies. Control
C57BLy6 mice of the same parental lineage were age and sex
matched (The Jackson Laboratory). Mice were evaluated daily
for clinical evidence of infection (weight loss, ruff led fur).
Aminoguanidine (Sigma) was used to block production of
NO. The drug was titrated in mice to establish a dosage that
was nontoxic over the time of the experiment. Aminoguani-
dine was administered by intraperitoneal injection once daily
(100 mgykg body weight). The treatment was started at the
time of infection and continued up to day 14 postchallenge.
Cytokine and iNOS Analysis. Expression of both mRNA
and protein for various cytokines was measured after infection
of the mice. For protein determination, sera (0.25 mlymouse)
was obtained by tail bleed and analyzed for level of protein by
ELISA. The serum levels of IFNg were tested by using a
commercially available kit (Endogen, Cambridge, MA) ac-
cording to the manufacturer’s instructions. Serum level of
TNFa were determined by ELISA as described (21).
Expression of mRNA for cytokines was performed by using
quantitative PCR (2). Briefly, splenocytes were isolated from
infected mice at indicated times postinfection (p.i.), and the
message for either IFNg or IL-10 was determined by the PQRS
quantitative method. The splenocytes from uninfected mice
were used to establish a baseline value of 1.0 against which the
level of message for cytokine in the test mice was quantitated.
For the measurement of iNOS expression, C57BLy6 mice
were infected orally. At various time points p.i. the mice were
sacrificed, and tissues were stored at 270°C. The pooled tissues
from three mice per group were homogenized in Trizol and
meshed in a tissue homogenizer. The RNA was extracted from
these samples, and reverse transcriptase–PCR was performed
as above. Each tissue from uninfected mice were used to
establish a baseline value of 1.0 against which the level of
message for this gene was quantitated.
Quantitation of Tissue Parasite Burden. Organs were re-
covered fresh from mice at 7 days p.i. Genomic DNA was
prepared according to standard protocol (22). Tissue was
homogenized in 0.1 M NaCly10 mM TriszHCl, pH 8y10 mM
EDTAy0.5% sodium deoxysulfatey0.2 mg/ml proteinase K.
The homogenate was incubated at 55°C until the lysate was
clear. Nucleic acids were collected after phenol-chloroform
extraction and ethanol precipitation. The RNA was digested in
a final concentration of 0.5 mgyml RNase A for 30 min at 37°C.
The isolated DNA was collected after phenol extraction and
ethanol precipitation. To quantify the number of parasites in
the tissue, Toxoplasma DNA was isolated from a known
number of cell culture-derived extracellular tachyzoites.
The Toxoplasma B1 gene sequence was used as a probe to
quantify tissue parasite load. This gene, previously used for
detection of this parasite (23), is a 35-fold repetitive sequence
and is found in all parasite strains, including 76K and RH. A
1,018-bp B1 sequence was amplified by using primers 59-
GTTGGTTCCGCCTCCTTCGTC and 39-CGAATCAACG-
GAACTGTAATG with a cycle of 1 min denaturation at 93°C,
1 min. annealing at 55°C and 1.5 min. extension at 72°C. A
corresponding 1-kb band observed on 1% agarose gel was
purified by QIA Gel Extraction Kit (Qiagen, Chatsworth CA)
and [32P]dATP tagged with a random-primed labeling kit
(Boehringer).
Slot blot hybridization was carried out as described (22).
Five micrograms of genomic DNA from each tissue was
denatured with 0.4 N NaOH and 0.2 mM EDTA and then
blotted onto a Hybond-N1 positive charged membrane. The
membranes were analyzed by autoradiography and scanned by
a Silverscanner III f latbed scanner Model G550A (Epson,
Torrance, CA). Data analysis was performed by using the
public domain NIH Image program (developed at the U.S.
National Institutes of Health and available from the Internet
at zippy.nimh.nih.gov).
Histopathological Analysis. Tissues were immediately fixed
in buffered 10% formalin, embedded, sectioned, and stained
with hematoxylin and eosin for routine histological examina-
tion. Sections were examined and photographed on Kodak
TMax film with an Olympus VanOx photomicrosope.
Statistical Analysis. Statistical analysis for the survival of
mice was performed by Fisher’s exact test, and difference in
survival time was determined by log rank test.
RESULTS
iNOS2y2 Mice Survive Primary Oral Infection with T.
gondii. To determine if deletion of the iNOS gene altered
innate resistance to the parasite, iNOS2y2 mice or their
genetically matched parental controls were infected orally with
tissue cysts containing bradyzoites. A significant difference in
time to death was observed between the parental and
iNOS2y2 strain. As shown in Fig. 1, all iNOS2y2 mice that
were infected with 50 or 100 76K strain tissue cysts per mouse
survived the acute phase of infection (day 1–12 p.i.). At no time
during the initial period of infection (day 0–21 days p.i.) did
these manifest evidence of clinical illness. In contrast, none of
the parental control mice survived beyond day 12 p.i. (P 5
.0001). When 20 cysts per mouse were used, the overall
mortality in the parental strain was reduced by 50% during the
first 12 days p.i. All of the iNOS2y2 mice infected with same
cyst load (20 cysts) survived beyond 12 days.
On day 27 p.i. the iNOS2y2 mice infected with T. gondii
began to die. By day 30, all of the iNOS2y2 mice were dead.
The difference in survival time p.i. was independent of the
number of cysts that were used for infection. In contrast,
parental mice that survived the initial stages of infection with
FIG. 1. Survival of iNOS2y2 mice from oral T. gondii challenge.
iNOS2y2 and parental mice (n 5 8ygroup) were orally infected with
different number of cysts containing bradyzoites of T. gondii and
mortality monitored. This study was performed three times with
similar findings. Data presented are representative of one experiment.
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20 cysts survived to day 90 when the experiment was termi-
nated. This observation suggested that the ability to produce
NO in the acute phase of infection may be detrimental to the
infected host, but that survivors could control chronic infec-
tion better than mice that lack the ability to produce NO.
Analysis of Cytokine Levels P.I. We measured cytokine
levels in spleen and serum to determine if an alteration in the
expression of mRNA or serum concentration of cytokine
proteins could account for the difference in susceptibility
between the parental and iNOS2y2 mouse strains. For this
analysis, IFNg and IL-10, two cytokines that are important in
mediating host immunity to this parasite, were studied. IFNg
is the principal mediator responsible for induction of NO in the
host. IL-10 was measured because of its known association
with immune down-regulation after T. gondii infection in mice
(24). Mice were infected orally with cysts, and their splenocytes
were isolated at day 7 p.i. These cells were analyzed for
cytokine message expression by quantitative PCR. As shown in
Fig. 2, the level of IFNg mRNA for both the wild-type and
iNOS2y2 mice was increased at least 10-fold over baseline.
The parental mice exhibited a several-fold increase in message
for IFNg when compared with the iNOS2y2 mice but there
was no appreciable difference in the level of message for IL-10
between the two mouse strains.
Serum level of IFNg and TNFa were quantitated p.i.
because induction of NO is dependent on costimulation of
effector cells with IFNg and another molecule such as TNFa.
Mice were infected orally with tissue cysts containing brady-
zoites. Sera from infected mice was collected 7 days p.i. and
assayed by ELISA for the level of IFNg and TNFa protein. As
shown in Table 1, there were increases in the levels of IFNg in
the sera of both parental and iNOS2y2 mice p.i. Oral
infection with cysts also resulted in a significant rise in the level
of circulating TNFa in both mouse strains. However, there was
no significant difference in the levels of either of these
cytokines between the parental and iNOS2y2 mice.
Histologic Analysis. Examination of tissues of T. gondii-
infected parental mice at day 7 showed small scattered nodules
composed of lymphocytes and a few polymorphonuclear neu-
trophils in the liver, spleen, pancreas, and brain, without easily
demonstrated parasites. As seen in Fig. 3A, the liver had
evidence of extensive fatty degeneration. There were only
scattered islands of preserved hepatocytes. The distal small
bowel was extensively necrotic, with full thickness inflamma-
tion and ulceration (Fig. 4 A and B). The brains of parental
mice had small foci of encephalitis scattered in the cortex and
periventricular gray matter, with predominant lymphocyte
infiltration and little necrosis (Fig. 3E).
In contrast, although the iNOS2y2 mice showed scattered
foci of lymphocytes and polymorphonuclear neutrophils in
similar tissue distribution to that seen in parentals, the liver
was morphologically intact, with little evidence of hepatocel-
lular dysfunction (Fig. 3B). Liver enzyme value was two times
greater in the infected parental compared with iNOS2y2
mice. The distal small bowel was normal (Fig. 4D). The brains
FIG. 2. Cytokine mRNA expression after T. gondii infection in
iNOS2y2 and parental mice. Mice were uninfected (2) or infected
orally (1) with 50 cysts and on day 7 p.i. splenocytes from three mice
were harvested and pooled, and mRNA expression for IFNg and IL-10
was assayed by reverse transcriptase–PCR. The differences in the
transcriptional level for both the genes are expressed relative to those
mice treated with saline (level designated as 1). The cDNA concen-
tration examined at each point was standardized to the hypoxanthine
phosphoribosyltransferase mRNA level (not shown).
Table 1. Serum cytokine levels of T. gondii-infected iNOS
2y2 mice
Mice IFNg, pgyml TNFa, pgyml
Parental uninfected 15 6 3.7 10.9 6 2.5
Parental infected 2,650 6 158 1,480 6 211
INOS 2y2 uninfected 16 6 4.7 13.6 6 6.4
INOS 2y2 infected 2,735 6 250 1,217 6 35.9
iNOS 2y2 and parental mice (n 5 3ygroup) were infected with 50
cysts of T. gondii and sera collected at day 7 p.i. The sera was
quantitated for both IFNg and TNFa by ELISA.
FIG. 3. Photomicrographs of mouse tissues 7 days p.i. with T.
gondii, processed as specified in Materials and Methods. Bars equal 30
mM. (A) Liver of C57BLy6 parental mouse showing an inflammatory
nodule surrounded by hepatocytes with marked fatty degeneration.
(B) Liver of iNOS2y2 mouse showing acute inflammatory nodule
among largely preserved hepatocytes. (C) Liver of sham-treated
C57BLy6 parental mouse with changes similar to the untreated
parental mouse. (D) Liver of aminoguanidine-treated parental mouse
with inflammation but preservation of hepatocyte morphology. (E)
Brain of parental mouse with acute inflammation and necrosis. (F)
Brain of iNOS2y2 mouse, with acute inflammation. Arrow indicates
T. gondii tachyzoites.
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of iNOS2y2 mice had larger, looser foci of encephalitis.
These brains included more extensive polymorphonuclear
neutrophil infiltration, necrosis, and demonstrable parasites
(Fig. 3F).
At day 27, both iNOS2y2 and parental mice exhibited foci
of necrosis and inflammation in brain and liver (data not
shown). The infected foci observed in the iNOS2y2 were
more extensive, compared with parental mice, suggesting that
iNOS2y2 mice have decreased ability to control hematoge-
nous spread of the parasite and parasite multiplication in the
chronic infection before their death at day 27–30 p.i.
A Southern blot analysis was done to quantitate the parasite
burden in the brain and liver tissue at day 7 p.i. Mice orally
infected with cysts were sacrificed at day 7 p.i., and brains and
liver were harvested for assay of the relative abundance of B1,
a T. gondii marker gene. Analysis of brain and liver tissue from
the two strains of mice demonstrated a significant increase in
the number of parasites in the iNOS2y2 mice compared with
the parental mice. As shown in Fig. 5, the number of parasites
in the brain of iNOS2y2 was 3.5 times over that observed in
the parental mice. An even greater difference in parasite
burden was observed in the liver where 15 times more parasites
were quantified in the iNOS2y2 compared with the parentals.
Treatment of Parental Mice with Aminoguanidine Prolongs
Time to Death. An analysis of the iNOS response in the
wild-type mice was undertaken to determine if this molecule
was up-regulated in response to infection. For this study, mice
were orally infected with cysts, and message for this molecule
was measured in the gut and liver at day 4 and 7 p.i. There is
a substantial increase in the expression of this molecule after
oral infection in the wild-type C57BLy6 mice (Fig. 6). The
expression of this molecule is at least 5-fold in the gut and
20-fold in the liver above baseline at day 7 p.i.
To determine if NO was the factor responsible for the
increased susceptibility and marked pathologic changes in the
parental mice, we treated mice with the NO inhibitor amino-
guanidine. Parental mice were infected orally with 50 cysts of
76K strain and treated daily with aminoguanidine beginning
the day of infection. Treatment with aminoguanidine was
continued for 2 weeks. Administration of this drug resulted in
the complete reversal of susceptibility to infection in the
parental mice (Fig. 7). The aminoguanidine-treated mice
survived beyond 20 days p.i. whereas all of the untreated
control mice died by day 8–9 p.i. Histological examination of
tissues from parental mice treated with aminoguanidine
showed scattered inflammatory liver lesions resembling the
iNOS2y2 mice, with preservation of hepatocyte morphology
(Fig. 3D). In contrast, the sham-treated infected controls
showed the same extensive fatty degeneration of hepatocytes
previously described (Fig. 3C).
A analysis of serum cytokine levels in infected parental mice
was performed to determine if aminoguanidine treatment
altered the cytokine response. Both aminoguanidine-treated
and untreated control mice were bled on day 7 p.i., and serum
was analyzed for presence of cytokine. As shown in Table 2 the
level of IFNg production in the two groups of mice was similar.
Further, there was no difference in the production of TNFa
between the aminoguanidine-treated and control groups.
DISCUSSION
In this report we demonstrate that mice with a targeted
deletion of the iNOS gene are significantly more resistant to
death during acute infection with the intracellular protozoan,
T. gondii than their control parentals. Mice with a disruption
of this gene are unable to produce NO in response to microbial
pathogen exposure (17). Oral infection of these mice with
tissue cysts containing bradyzoites resulted in longer survival
than the parental control mice. At 7–11 days p.i., morphologic
changes were observed in the liver and distal small intestine of
parental, but not iNOS2y2, mice. At the same time, we also
observed a significant increase in parasite burden in the brain
and liver tissue of the iNOS mice compared with parentals.
Treatment of parental mice with aminoguanidine, an inhibitor
of NO synthase, rendered the mice resistant to early death
after oral parasite infection. Moreover, aminoguanidine treat-
ment reversed the pathologic changes noted in the liver and gut
of the parental mice. These findings suggest that NO has both
a microbicidal role and a detrimental role in stimulating
FIG. 4. Photomicrographs of mouse distal ileum 7 days p.i. with T.
gondii. (A and B) Parental C57BLy6 mouse showing acute necrosis of
small bowel villi with acute inflammatory infiltration and ulceration.
(A) Bar equals 100 mM. (B) Bar equals 200 mM. (C) Parental mouse
treated with aminoguanidine showing preservation of small bowel
epithelium. Bar equals 100 mM. (D) iNOS2y2 mouse with normal
small bowel epithelium. Bar equals 75 mM.
FIG. 5. Levels of parasite DNA in the organs of iNOS2y2 and
parental mice infected with T. gondii. Mice (n 5 3ygroup) were
infected orally with 50 cysts of T. gondii. DNA was prepared from the
brain and liver of mice 7 days p.i. A slot blot analysis was probed with
T. gondii-specific B1 sequence. The scanned auto radiogram was
quantitated by NIH Image that used DNA from a known number of
extracellular tachyzoites as control. Bars represent the average number
of parasites detected in each tissue.
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immunopathologic changes in tissues, which may lead to the
death of the infected host.
Although the importance of IFNg in stimulating host im-
munity to T. gondii is well appreciated, the mechanism by
which this cytokine prevents death of the host in the murine
model is not well understood. The importance of IFNg-
mediated NO production in host immunity against acute T.
gondii has been observed. Recent studies by Scharton-Kursten
et al. (25) have suggested that NO is more important in host
immunity against chronic infection. We observed that NO may
not be an essential mediator of protection against acute T.
gondii in mice that have a targeted deletion in the gene for IRF
(15). After intraperitoneal infection with T. gondii tachyzoites,
these mice express significant quantity of mRNA for IFNg in
their splenocytes, but are unable to produce measurable
amounts of nitrite, a metabolic product of NO biosynthesis.
These mice were observed to be significantly more susceptible
to acute Toxoplasma infection, which we presumed to be
secondary to the loss of their ability to produce NO in response
to microbial pathogens. However, it now has been shown that
IRF2y2 mice have an inherent defect in both the production
of CD81 T cells (16) and functionally adequate NK cells.
Because both of these cell types are associated with host
immunity to Toxoplasma it is possible that the increased
susceptibility of the IRF2y2 mice to T. gondii infection could
be attributed to either immunologic defect.
To better evaluate the role of NO during acute T. gondii
infection, mice with a targeted disruption in the iNOS gene
were used (17). Current evidence suggests that these mice are
immunologically intact except for their inability to produce
inducible NO. These mice are unable to produce NO in
response to infection with the intracellular bacteria, Listeria
monocytogenes (17). Although iNOS2y2 mice were able to
survive acute infection, none of the mice survived beyond day
30, and all mice had histologic evidence of tissue infection and
chronic inflammatory changes. The observation that chroni-
cally infected iNOS2y2 eventually succumb to fatal T. gondii
infection is consistent with the recent report that NO is an
important modulator of long-term immunity against this par-
asite (25). In the absence of NO, these mice eventually die from
chronic, progressive infection.
During acute infection, however, NO also appears to be a
modulator of immunopathogenesis. In the most susceptible
strain of mouse, C57BLy6 (26), histopathological analysis at
day 7 p.i. demonstrated marked changes in the liver and
intestine. Quantitative measure of iNOS expression in the
wild-type C57BLy6 mice showed a substantial rise in the
production of this molecule in response to oral infection. The
histologic analysis included many foci of inflammatory cells
with little evidence of either intracellular or extracellular
Toxoplasma. In the liver, hepatic degeneration was character-
ized by fatty infiltration throughout the parenchyma. Intestinal
inflammation was evident in the distal ileum with loss of the
brush border, necrosis, and acute inflammatory infiltration.
Although it has been suggested that NO may not be essential
for host protection against acute infection (15, 25) a quanti-
tative assay of tissue parasite burden were provided. The
histologic and quantitative analysis that NO production can
reduce, but not eliminate, parasite burden during acute infec-
tion. However, the price to pay for this exuberant immunologic
response can be detrimental to the host.
FIG. 7. Effect of aminoguanidine treatment on the susceptibility of
mice infected with T. gondii. Parental mice (n 5 6ygroup) were
infected with 50 cysts and treated daily with 100 mgykg body weight
of aminoguanidine. Control mice were infected and administered
saline. The experiment was performed twice with similar findings. The
data presented is representative of one experiment.
FIG. 6. Levels of iNOS message in the intestine and liver of
C57BLy6 mice infected with T. gondii. Mice were infected orally with
cysts. On day 0, 4, and 7 p.i. the liver and distal ileum were isolated and
stored at 270°C. The pooled tissues from three mice at each time point
were homogenized, and mRNA expression for iNOS was assayed by
reverse transcription–PCR. The transcriptional level is expressed
relative to uninfected mice (designated as 1). The cDNA concentration
examined at each point was standardized to the hypoxanthine phos-
phoribosyltransferase mRNA level (not shown).
Table 2. Serum cytokine levels of T. gondii-infected mice treated
with aminoguanidine
Mice IFNg pgyml TNFa pgyml
Uninfected 1 saline 28 6 12 30 6 17
Infected 1 saline 2,764 6 216 1,336 6 44
Uninfected 1 AG 35 6 16 28 6 16
Infected 1 AG 2,865 6 192 1,320 6 161
Parental mice (n 5 3ygroup) were treated daily with 100 mgykg
body weight of aminoguanidine starting on the day of infection. The
sera was collected at day 7 p.i. and the cytokine levels of IFNg and
TNFa were determined by ELISA. AG, aminoguanidine.
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Our observations indicate that the degenerative changes
noted in the liver and bowel of parental mice are secondary to
NO rather than a direct effect of cytokines. The role of TNFa
and IFNg in stimulating immunopathologic changes during
intracellular infections has been reported (27, 28). TNFa
increases susceptibility during murine Trypanosome cruzii in-
fection (29). The observation that IL-10-deleted mice are more
susceptible to acute T. gondii infection has been attributed to
increased levels of TNFa and IFNg production (30, 31).
Treatment of susceptible C57BLy6 mice with anti-IFNg anti-
body prevents intestinal necrosis because of T. gondii infection
(29). Our data suggests that it is more likely a local tissue
abundance of NO and not the level of IFNg produced by the
host that is responsible for the pathologic changes in the gut
(28) and possibly in the liver. We observed that the pathologic
changes in the liver and gut are preventable and appear to be
independent of the systemic level of either IFNg or TNFa. This
observation has suggested to us and others (25) that IFNg may
stimulate host immunity to this parasite by alternative path-
ways.
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